Logotype for Neuroone Medical Technologies Corp

Neuroone Medical Technologies (NMTC) investor relations material

Neuroone Medical Technologies Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Neuroone Medical Technologies Corp
Q4 2025 earnings summary17 Dec, 2025

Executive summary

  • Achieved record product sales growth of 163% to $9.1 million for fiscal 2025, with Q4 product revenue surging 907% to $2.7 million, marking the most successful year in company history.

  • Gross margin improved to 56.5% for the year, with Q4 gross margin at 55.8%.

  • Net loss narrowed by 71% to $3.6 million ($0.09/share) for the year, compared to a $12.3 million loss in 2024.

  • Strengthened the balance sheet with an $8.2 million capital raise, ending the year with $6.6 million in cash and no debt.

  • Operating expenses declined for the second consecutive year, down 4.6% to $12.4 million.

Financial highlights

  • Product gross profit for the year was $5.1 million (56.5% margin), up from $1.1 million (31.3%).

  • License revenue of $3 million in fiscal 2025 from the expanded Zimmer Biomet agreement.

  • Working capital increased to $7.9 million from $2.4 million year-over-year.

  • SG&A expenses decreased 6.6% to $7.4 million; R&D expenses slightly decreased to $5.0 million.

  • Operating expenses decreased 2% in Q4 and 5% for the full year; net loss improved by 52% in Q4 and 71% for the year.

Outlook and guidance

  • Financial guidance for fiscal 2026 will be provided after receiving a final forecast from Zimmer Biomet.

  • Anticipated growth does not include potential revenue from trigeminal neuralgia ablation, pain management strategic agreements, or drug delivery partnerships.

  • Company expects to be funded through at least fiscal 2026, potentially longer if milestones are met.

  • Anticipates commercial readiness for pre-clinical drug delivery devices in 2026.

  • Pursuing ISO 13485 certification for international expansion.

NASDAQ compliance plan details?
Drug delivery partnership strategy?
OneRF trigeminal commercialization plan?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Neuroone Medical Technologies earnings date

Logotype for Neuroone Medical Technologies Corp
Q1 202611 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Neuroone Medical Technologies earnings date

Logotype for Neuroone Medical Technologies Corp
Q1 202611 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

NeuroOne Medical Technologies Corp (NMTC) is a medical technology company that specializes in the development and commercialization of innovative solutions for neurologic conditions. The company's focus is on providing minimally invasive and high-definition solutions for electroencephalogram (EEG) recording, brain stimulation, and ablation procedures for patients suffering from a variety of neurological disorders. These disorders include epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries, among others. NeuroOne's technology aims to improve patient outcomes and reduce procedural costs. The company is also exploring potential applications of its technology in other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage